Successful Exit: BayBG Venture Capital Sells Its Stake in Specialty Pharma Company AMW
05 March 2026
BayBG Venture Capital successfully exits AMW, a specialty pharma company for biodegradable drug delivery systems. Ren Life Sciences and Juno Capital Partners become new majority shareholders as AMW enters its next growth phase.
Nearly 200 startups, investors, and ecosystem partners gathered at the Venture Capital Kickoff 2026 in Munich, one of the key networking events for the Bavarian VC community.
BayBG Venture Capital provides growth financing for HealthTech platform AlfaDocs
01 October 2025
We’re proud to continue our partnership with AlfaDocs – the patient-first cloud platform transforming the digitalization of medical and dental practices in Europe.
Joint Kick-off by BayBG Venture Capital, Cipio Partners, VC Magazin, and WIPIT
11 January 2025
The Munich VC scene came together once again for the traditional Venture Capital Kick-off hosted at BayBG. More than 200 startups, investors, and key players gathered for this collaborative event organized by BayBG, Cipio Partners, VC Magazin, and the law firm WIPIT.
)
)
)
)
)
)
)
)